Veradigm Inc.

Veradigm Inc. provides IT solutions to healthcare providers, payers, and biopharma markets globally. Solutions for healthcare providers include Practice Management software, EHRs, and Patient Engagement Platform. The company also offers revenue cycle management and electronic health records solutions. For network partners, Veradigm provides API connectivity solutions and Channel Partner Program. Health plans and payers receive risk adjustment, quality management, data exchange+coding, and provider engagement solutions. Biopharma customers benefit from real-world data, evidence analytics, therapy-focused data, and Digital Health Media solutions. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Overview

Sector

Health Information Services

Target Price

0.0 USD

Current Price

4.9 USD

Potential

-100%

Strengths

Price to book ratio (0.53) is lower than the sector mean (2.07).
EV/EBITDA (4.58) is lower than the sector mean (41.92).
Price to free cash flow (6.43) is lower than the sector mean.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
EV/EBIT (100.00) is significantly higher than the sector mean.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	4.6
Price/Free Cash Flow'	6.4
ROIC	9.3%
Net Debt/EBITDA	100.0